Rockefeller Capital Management
PRCT icon

Rockefeller Capital Management’s Procept Biorobotics PRCT Stock Holding History

Rockefeller Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.46M Buy
298,400
+70,214
+31% +$1.98M 0.01% 776
2025
Q4 		$7.18M Buy
228,186
+220,115
+2,727% +$7.3M 0.01% 768
2025
Q3 		$288K Buy
+8,071
New +$369K ﹤0.01% 2040

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rockefeller Capital Management's PRCT Position: Q1 2026 in Review

Rockefeller Capital Management increased its Procept Biorobotics (PRCT) stake by 31% in Q1 2026, buying an estimated $1.98M and bringing the position to 298,400 shares worth $7.46M. The position accounts for 0.01% of the portfolio, ranked #776.

Rockefeller Capital Management first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Rockefeller Capital Management held 298,400 shares of Procept Biorobotics worth $7.46M as of Q1 2026.
  • Rockefeller Capital Management bought 70,214 Procept Biorobotics shares in Q1 2026, an estimated $1.98M.
  • Procept Biorobotics made up 0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #776 holding.
  • Rockefeller Capital Management first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.